/NOT FOR DISSEMINATION IN THE
UNITED STATES OR FOR DISTRIBUTION TO U.S. WIRE
SERVICES./
WINNIPEG, Sept. 10, 2018
/CNW/ - DELTA 9 CANNABIS INC. (TSXV: NINE) ("Delta 9" or the
"Company") is pleased to announce that Mr. Hugh H. Aird has joined the Company's board of
directors. Mr. Aird's appointment follows the resignation of
Anthony Jackson as a director of the
Company.
Mr. Aird is a highly respected investment banker with a 35-year
career that included more than 150 completed debt and equity
financings and several merger and acquisition assignments with some
of Canada's top investment firms.
After attending Harvard University,
Mr. Aird went on to work as vice-president of Dominion Securities
from 1978 to 1985. Subsequently Mr. Aird founded and served as CEO
of Great Lakes Capital Markets before becoming Chairman of Trilon
Financial Corp. Mr. Aird served as Vice-Chairman of Midland Walwyn
(later Merrill Lynch Canada) from 1995 to 2000, after which he left
to take over as President and CEO of Berenson Minella (Canada) in 2001.
Mr. Aird also held several public and private board positions
from 1990 to the present day, including among others Trilon
Financial, Royal LePage Real Estate, Edelman Canada, and currently acts as Chair at
Bainagowan Investments.
Delta 9 CFO Brent Bottomley
stated that Mr. Aird brings a wealth of investment knowledge and
operational excellence to the Company's board of directors.
"As one of Canada's most respected relationship bankers, Hugh
has also founded and operated many companies," Bottomley said. "As
our Company continues to grow with the anticipated launch of full
cannabis legalization in October, his guidance in banking,
investments, corporate governance and operations will be critical
to Delta 9's success."
Mr. Aird said he is excited to be joining one of Canada's
leaders in the rapidly growing legal cannabis industry.
"Canada is leading the way in the commercialization of both
medical and recreational cannabis, and Delta 9 is in the forefront
as a vertically integrated producer, retailer, and exporter of
cannabis," Aird said. "I look forward to helping Delta 9 grow
across Canada and into international markets as this industry
develops."
Bottomley also exchanged his thanks to Mr. Jackson for his
service on the Delta 9 board of directors.
"Anthony joined our Board at a critical time in our Company's
development, and was very helpful in guiding our team as we made
the transition from a privately held company to a public company on
the TSX Venture Exchange. We all want to extend our thanks for his
able assistance over this very eventful year."
The appointment of Mr. Aird as a director of the Company remains
subject to the approval of the TSX Venture Exchange.
About Delta 9 Cannabis Inc.
Delta 9 Cannabis was the
fourth producer in Canada licensed
to produce legal cannabis. Delta 9 now operates its wholly-owned
subsidiary, Delta 9 Bio-Tech Inc., as a licensed producer of
medical marijuana pursuant to the ACMPR and operates an 80,000
square foot production facility in Winnipeg, Manitoba, Canada. Delta 9 also owns
50 per cent of the 70,000 square foot Delta
West facility in Alberta,
and co-owns the Delta West Lifestyles cannabis retail operation.
Delta 9's shares trade on the TSX Venture Exchange under the symbol
"NINE".
Neither the TSX Venture Exchange nor its Regulation
Services Provider (as that term is defined in the policies of the
TSX Venture Exchange) accepts responsibility for the adequacy or
accuracy of this release.
Disclaimer for Forward-Looking Information
Certain statements in this release are forward-looking
statements, which reflect the expectations of management regarding
the Company's future business plans and other matters.
Forward-looking statements consist of statements that are not
purely historical, including any statements regarding beliefs,
plans, expectations or intentions regarding the future. Forward
looking statements in this news release include statements relating
to: (i) Delta 9's expansion plans; and (ii) legalization of
recreational cannabis in Canada.
Such statements are subject to risks and uncertainties that may
cause actual results, performance or developments to differ
materially from those contained in the statements, including those
risk factors set forth in the annual information form of Delta 9
dated May 31, 2018 which has been
filed on SEDAR. No assurance can be given that any of the events
anticipated by the forward-looking statements will occur or, if
they do occur, what benefits the Company will obtain from them.
Readers are urged to consider these factors carefully in evaluating
the forward-looking statements contained in this news release and
are cautioned not to place undue reliance on such forward-looking
statements, which are qualified in their entirety by these
cautionary statements. These forward-looking statements are made as
of the date hereof and the Company disclaims any intent or
obligation to update publicly any forward-looking statements,
whether as a result of new information, future events or results or
otherwise, except as required by applicable securities
laws.
SOURCE Delta 9 Cannabis Inc.